The project design was assigned to Tsolakis Architects following an extensive competitive selection process.

Sklavenitis leads the sector.

The issuance will have a minimum size of €90 million and a maturity of five years.

The new facility is considered the largest pharmalogistics unit in Southeast Europe.

Winners and losers in tourist destinations and major cities.

ELSTAT data indicate that long-term trends remain negative.